Patent AT-E400665-T1: [Translated] SGK AND NEDD AS DIAGNOSTIC AND THERAPEUTIC TARGETS
Description
The invention relates to the use of a substance for the diagnostic detection of Sgk, especially Sgk1 and/or Sgk3, and/or PKB and/or Nedd, especially Nedd4-2, and to the use of active ingredients which influence glucose transport for treating diseases associated with disturbed glucose transport, and for fattening animals. The invention also relates to a diagnosis kit and a pharmaceutical composition comprising an active quantity of at least one active ingredient which influences glucose transport. The invention further relates to a method for producing transgenic animals.
Resources
| Name |
Format |
Description |
Link |
|
21 |
Access the complete Patent AT-E400665-T1: [Translated] SGK AND NEDD AS DIAGNOSTIC AND THERAPEUTIC TARGETS on the official website. |
https://pubchem.ncbi.nlm.nih.gov/patent/AT-E400665-T1 |
Tags
- patent
- chemistry
- research
- innovation
- pubchem